TGTX - Company ID 0001001316
TG THERAPEUTICS, INC. trades as TGTX and has a market capitalization of $8.96 B, making it the #1027 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $616.29M, up 87.3% from the prior year and net income of $447.20M. This page tracks TG THERAPEUTICS, INC. through 1,133 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years TG THERAPEUTICS, INC.'s revenue grew from $152.00K to $616.29M, a compound annual growth rate of 151.7%. Net profit margin expanded from -5204.1% to 72.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Proxy statement | DEF 14A | 2026-04-30 |
| SCHEDULE 13G | - | 2026-04-29 |
| SCHEDULE 13G/A | - | 2026-03-27 |
| Major company event | 8-K | 2026-03-20 |
| Annual report | 10-K | 2026-02-27 |
| Major company event | 8-K | 2026-02-26 |
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance | TG Therapeutics, Inc.
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance | TG Therapeutics, Inc.
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance | TG Therapeutics, Inc.
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance | TG Therapeutics, Inc.
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance | TG Therapeutics, Inc.
The largest companies sharing TG THERAPEUTICS, INC.'s SEC industry classification (pharmaceutical preparations).
TG THERAPEUTICS, INC. (TGTX) has a market capitalization of $8.96 B as of 2026-07-09, ranking #1027 among US-listed companies.
TG THERAPEUTICS, INC. reported revenue of $616.29M for fiscal year 2025, an increase of 87.3% year over year.
Yes. TG THERAPEUTICS, INC. reported net income of $447.20M in its latest fiscal year.